181 - 190 of 4301 Drugs
Afstyla (antihemophilic factor recombinant intravenous injection)
Afstyla [antihemophilic factor (recombinant), single chain for intravenous injection] is a recombinant, antihemophilic factor indicated in adults and children with hemophilia A (congenital Factor VIII deficiency) for on-demand treatment and control of bleeding episodes, routine prophylaxis to reduce the frequency of bleeding episodes, and perioperative management of bleeding.
Aftera (levonorgestrel tablet)
Aftera (levonorgestrel tablet) is emergency contraception that helps prevent pregnancy after birth control failure or unprotected sex. It is a backup method of preventing pregnancy and should not be used as regular birth control.
AfterPill (levonorgestrel tablet, 1.5 mg)
AfterPill (levonorgestrel tablet) is emergency contraception that helps prevent pregnancy after birth control failure or unprotected sex. It is a backup method of preventing pregnancy and should not be used as regular birth control.
Fabrazyme (agalsidase beta)
Fabrazyme (agalsidase beta) for intravenous infusion is a man-made form of the naturally-occurring enzyme a-galactosidase A that is used in the treatment of Fabry disease.
Agenerase Capsules (amprenavir capsules)
Agenerase (amprenavir) is a type of antiviral medication called a protease inhibitor used to treat HIV, which causes acquired immunodeficiency syndrome (AIDS). Agenerase is not a cure for HIV or AIDS. The brand name Agenerase is discontinued, but generic versions may be available.
Aggrastat (tirofiban hcl)
Aggrastat (tirofiban hydrochloride) is an antiplatelet drug that works by keeping platelets in the blood from coagulating (clotting) used to prevent blood clots or heart attack in people with severe chest pain or other conditions, and in those who are undergoing an angioplasty procedure (to open blocked arteries).
Aggrenox (aspirin, extended-release dipyridamole capsules)
Aggrenox (aspirin, extended-release dipyridamole) is a combination of a salicylate and a platelet aggregation inhibitor used to reduce the risk of stroke in people who have had blood clots or a "mini-stroke" (also called a transient ischemic attack or TIA). Aggrenox may be available in generic form.
Agrylin (anagrelide)
Agrylin (anagrelide hydrochloride) is a platelet-reducing agent used to treat thrombocythemia (also called thrombocytosis), a blood cell disorder in which too many platelet cells are produced, causing bleeding or blood-clotting problems. Agrylin is available in generic form.